Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial Read more
Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Read more
FDA Approves VNS Therapy Treatment for Drug-Resistant Epilepsy in Children as Young as Four Years Old Read more